Latest News[News Brief] FDA Approves Tremfya Label Expansion for Psoriatic Arthritis[News Brief] Pfizer Receives FDA Approval for Expanded Hympavzi Use[News Brief] Everest Medicines Licences Sumecigrel for Asia-Pacific Development[News Brief] PharmaEssentia Receives Taiwan Approval for Besremi in ETFeatured Press ReleasesKL Wellness City: Powering Malaysia’s Healthcare TourismHealth365 Makes The News: CEO George Foo Quoted In The Business Times On Cross-Border Health Screening Surge[Press Release] – Johnson & Johnson Milestone 100,000 Eyes Implanted With TECNIS ODYSSEY IOL In The U.S. Singapore Press Releases[News Brief] Dymax Releases Low Viscosity Medical Adhesive[News Brief] Agilent and NATi Partner on Oligonucleotide Research in Singapore[News Brief] AstraZeneca, Roche Expand Digital Pathology in AsiaASEAN Press Releases[News Brief] Thailand FDA Approves Ravidasvir for Hepatitis C Treatment[News Brief] Philippine Pharma & Healthcare Expo 2026 Holds Media Interaction Ahead of 2026 Edition[News Brief] IMCAS Asia 2026 to Convene Dermatology and Aesthetic Medicine ProfessionalsAsia Press Releases[News Brief] PharmaEssentia Receives Taiwan Approval for Besremi in ET[News Brief] Formosa Pharma Signs Licensing Deal With Samil Pharmaceutical[News Brief] Zhenjiankang Medical Passes Hong Kong Listing HearingGlobal Press Releases[News Brief] FDA Approves Tremfya Label Expansion for Psoriatic Arthritis[News Brief] Pfizer Receives FDA Approval for Expanded Hympavzi Use[News Brief] Everest Medicines Licences Sumecigrel for Asia-Pacific Development
Health365 Makes The News: CEO George Foo Quoted In The Business Times On Cross-Border Health Screening Surge
[Press Release] – Johnson & Johnson Milestone 100,000 Eyes Implanted With TECNIS ODYSSEY IOL In The U.S.
